186 related articles for article (PubMed ID: 30089943)
41. Correlation of histologic grade of breast carcinoma with cytologic features on fine-needle aspiration of the breast.
Ducatman BS; Emery ST; Wang HH
Mod Pathol; 1993 Sep; 6(5):539-43. PubMed ID: 8248109
[TBL] [Abstract][Full Text] [Related]
42. Correlation of Nuclear Morphometry with Clinicopathologic Parameters in Malignant Breast Aspirates.
Kalhan S; Garg S; Satarkar R; Sharma P; Hasija S; Sharma S
South Asian J Cancer; 2021 Apr; 10(2):64-68. PubMed ID: 34568216
[No Abstract] [Full Text] [Related]
43. Apoptosis in breast cancer.
Nijhawan R; Hemachandran M; Joshi K
Acta Cytol; 2003; 47(2):193-6. PubMed ID: 12685188
[TBL] [Abstract][Full Text] [Related]
44. Cytological grading of breast carcinoma with histological correlation.
Milentijević MJ; Ilić R; Milentijević I
J BUON; 2005; 10(2):251-6. PubMed ID: 17343338
[TBL] [Abstract][Full Text] [Related]
45. Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading.
Sauer T; Lømo J; Garred O; Naess O
Cancer; 2005 Feb; 105(1):21-7. PubMed ID: 15593325
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.
Mills SW; Musil KM; Davies JL; Hendrick S; Duncan C; Jackson ML; Kidney B; Philibert H; Wobeser BK; Simko E
Vet Pathol; 2015 Mar; 52(2):238-49. PubMed ID: 25060990
[TBL] [Abstract][Full Text] [Related]
47. Cytological grading of breast carcinoma--a feasible proposition?
Hunt CM; Ellis IO; Elston CW; Locker A; Pearson D; Blamey RW
Cytopathology; 1990; 1(5):287-95. PubMed ID: 2101675
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.
Genestie C; Zafrani B; Asselain B; Fourquet A; Rozan S; Validire P; Vincent-Salomon A; Sastre-Garau X
Anticancer Res; 1998; 18(1B):571-6. PubMed ID: 9568179
[TBL] [Abstract][Full Text] [Related]
49. Expansion of Masood's cytologic index for breast carcinoma and its validity.
Rekha Ts; Nandini N; Dhar M
J Cytol; 2013 Oct; 30(4):233-6. PubMed ID: 24648665
[TBL] [Abstract][Full Text] [Related]
50. Introduction of the cytological grading, the nuclear area, the DNA index and the DNA histogram type in the setting up of a score for ductal breast carcinoma.
Budel V; Merle S; Gasperin P; Collet JF; De Maublanc MA; Kiss R
Anticancer Res; 1994; 14(6B):2845-51. PubMed ID: 7532932
[TBL] [Abstract][Full Text] [Related]
51. A comparative and evaluative study of cytological and histological grading system profile in malignant neoplasm of breast--an important prognostic factor.
Meena SP; Hemrajani DK; Joshi N
Indian J Pathol Microbiol; 2006 Apr; 49(2):199-202. PubMed ID: 16933714
[TBL] [Abstract][Full Text] [Related]
52. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
53. Cytologic nuclear grading of fine needle cytopunctures of breast carcinoma. Comparison with histologic nuclear grading and image cytometric data.
Briffod M; Le Doussal V; Spyratos F
Anal Quant Cytol Histol; 1997 Apr; 19(2):114-22. PubMed ID: 9113304
[TBL] [Abstract][Full Text] [Related]
54. A morphometric approach in breast cytology--geometrical descriptors in the differentiation between benign and malignant lesions.
Mihalache D; Giuşcă SE; Balan R; Amălinei C; Grigoraş A; Căruntu ID
Rom J Morphol Embryol; 2014; 55(2):273-7. PubMed ID: 24969974
[TBL] [Abstract][Full Text] [Related]
55. Fine needle aspiration cytology of lobular breast carcinoma. Comparison with other breast lesions.
Rajesh L; Dey P; Joshi K
Acta Cytol; 2003; 47(2):177-82. PubMed ID: 12685185
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma.
Toi PC; Neelaiah S; Dharanipragada K; Surendra K
J Cytol; 2018; 35(4):223-228. PubMed ID: 30498294
[TBL] [Abstract][Full Text] [Related]
57. Role of Nuclear Morphometry in Breast Cancer and its Correlation with Cytomorphological Grading of Breast Cancer: A Study of 64 Cases.
Kashyap A; Jain M; Shukla S; Andley M
J Cytol; 2018; 35(1):41-45. PubMed ID: 29403169
[TBL] [Abstract][Full Text] [Related]
58. Cytological grading, apoptosis, and Bcl-2 protein expression in breast cancer.
Hemachandran M; Nijhawan R; Joshi K
Diagn Cytopathol; 2002 Jun; 26(6):356-9. PubMed ID: 12112824
[TBL] [Abstract][Full Text] [Related]
59. Semiquantitative analyses of fine needle aspirates from benign and malignant breast lesions.
Thomas JS; Mallon EA; George WD
J Clin Pathol; 1989 Jan; 42(1):28-34. PubMed ID: 2537853
[TBL] [Abstract][Full Text] [Related]
60. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
Amat S; Penault-Llorca F; Cure H; Le Bouedëc G; Achard JL; Van Praagh I; Feillel V; Mouret-Reynier MA; Dauplat J; Chollet P
Int J Oncol; 2002 Apr; 20(4):791-6. PubMed ID: 11894126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
